Gyvensenos medicina - Company finances
- The company is late in submitting financial data for the previous financial year.
- Latest financial data up to 2024-12-31.
|
EUR
|
2020
From: 2020-12-10
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 0 | 363 | 34,500 | 49,988 | 11,300 |
| Profit before tax | 0 | 363 | 14 | -587 | -367 |
| Net profit | 0 | 363 | 14 | -587 | -367 |
| Equity | 0 | 363 | 377 | -210 | -577 |
| Liabilities | 0 | 100 | 0 | 253 | 657 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 |
| Current assets | 0 | 463 | 377 | 43 | 80 |
| Total assets | 0 | 463 | 377 | 43 | 80 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | +9404.1% | +44.9% | -77.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | 78.4% | 3.7% | -1365.1% | -458.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 100.0% | 3.7% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 100.0% | 0.0% | -1.2% | -3.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 100.0% | 0.0% | -1.2% | -3.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.3 | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gyvensenos medicina - Social security debts
The company had no debts to Sodra
Gyvensenos medicina - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.